HK1220413A1 - 预防胃肠梗阻的材料 - Google Patents

预防胃肠梗阻的材料 Download PDF

Info

Publication number
HK1220413A1
HK1220413A1 HK16108480.2A HK16108480A HK1220413A1 HK 1220413 A1 HK1220413 A1 HK 1220413A1 HK 16108480 A HK16108480 A HK 16108480A HK 1220413 A1 HK1220413 A1 HK 1220413A1
Authority
HK
Hong Kong
Prior art keywords
materials
gastrointestinal obstruction
obstruction prevention
peptide
amino acids
Prior art date
Application number
HK16108480.2A
Other languages
English (en)
Chinese (zh)
Inventor
Satoru Kobayashi
Toshio Uraoka
Naohisa Yahagi
Original Assignee
3-D Matrix, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3-D Matrix, Ltd. filed Critical 3-D Matrix, Ltd.
Publication of HK1220413A1 publication Critical patent/HK1220413A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16108480.2A 2013-03-14 2014-03-13 预防胃肠梗阻的材料 HK1220413A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785582P 2013-03-14 2013-03-14
US61/785,582 2013-03-14
PCT/IB2014/059748 WO2014141143A1 (en) 2013-03-14 2014-03-13 Materials for gastrointestinal obstruction prevention

Publications (1)

Publication Number Publication Date
HK1220413A1 true HK1220413A1 (zh) 2017-05-05

Family

ID=50424678

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108480.2A HK1220413A1 (zh) 2013-03-14 2014-03-13 预防胃肠梗阻的材料

Country Status (10)

Country Link
US (1) US9724448B2 (enExample)
EP (1) EP2968693B1 (enExample)
JP (2) JP6478927B2 (enExample)
KR (1) KR20160003651A (enExample)
CN (1) CN105339020B (enExample)
AU (1) AU2014229273B2 (enExample)
BR (1) BR112015022747B1 (enExample)
CA (1) CA2905182A1 (enExample)
HK (1) HK1220413A1 (enExample)
WO (1) WO2014141143A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345433B1 (en) 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
JP6389170B2 (ja) 2012-07-06 2018-09-12 スリーディー マトリックス， エルティーディー３−Ｄ Ｍａｔｒｉｘ， Ｌｔｄ． ペプチド溶液のためのフィル−フィニッシュ過程
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
CA2939696C (en) * 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
WO2018005427A1 (en) * 2016-06-27 2018-01-04 3-D Matrix, Ltd. Self-assembling peptide matrix for the prevention of esophageal stricture after endoscopic dissection
JP7012950B2 (ja) * 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
WO2020008377A2 (en) 2018-07-03 2020-01-09 3-D Matrix, Ltd. Ionic self-assembling peptides
WO2020071527A1 (ja) * 2018-10-05 2020-04-09 学校法人 久留米大学 腸管における潰瘍または瘻孔の治療または予防のための医薬組成物
EP3952973B1 (en) 2019-06-13 2023-06-07 Hollister Incorporated Reusable urinary catheter products
AU2020304005B2 (en) 2019-06-25 2025-12-04 Hollister Incorporated Reusable urinary catheter products
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
JP2024506048A (ja) * 2021-02-10 2024-02-08 株式会社スリー・ディー・マトリックス 特異的な自己組織化ペプチドｒａｄａ１６を含む、炎症性腸疾患などの下部消化管疾患を治療又は予防するための医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) * 2005-01-13 2005-02-23 Renovo Ltd Medicaments
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
US8022178B2 (en) * 2006-09-26 2011-09-20 Massachusetts Institute Of Technology Modified self-assembling peptides
EP2229960B1 (en) * 2007-12-05 2015-04-08 3-D Matrix, Ltd. Wound healing/skin reconstruction material
EP2345433B1 (en) * 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug

Also Published As

Publication number Publication date
WO2014141143A1 (en) 2014-09-18
AU2014229273A1 (en) 2015-10-08
US9724448B2 (en) 2017-08-08
CN105339020B (zh) 2020-06-16
US20160000966A1 (en) 2016-01-07
CA2905182A1 (en) 2014-09-18
JP6478927B2 (ja) 2019-03-06
CN105339020A (zh) 2016-02-17
AU2014229273B2 (en) 2016-12-01
EP2968693A1 (en) 2016-01-20
BR112015022747B1 (pt) 2020-10-13
KR20160003651A (ko) 2016-01-11
JP2016515113A (ja) 2016-05-26
BR112015022747A2 (pt) 2017-07-18
EP2968693B1 (en) 2022-06-01
BR112015022747A8 (pt) 2019-12-03
JP2018115208A (ja) 2018-07-26

Similar Documents

Publication Publication Date Title
HK1220413A1 (zh) 预防胃肠梗阻的材料
IL262038B (en) Bicyclic heterocycles and pharmaceutical compositions thereof as inhibitors of one or more fgfr enzymes which are useful in the treatment of fgfr-related diseases
IL276153B (en) c1-inh preparations and methods for preventing and treating disorders associated with c1 esterase inhibitor deficiency
EP3337782A4 (en) DIACEREIN OR ITS ANALOGUE FOR INHIBITING THE EXPRESSION OF ASC, NLRP3 AND / OR FOR THE FORMATION OF NLRP3 INFLAMMASOM COMPLEX
EP3267994A4 (en) Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
HK1220145A1 (zh) 胆漏治疗
MX2016016832A (es) Materiales y metodos para llenar cavidades oseas.
EP3094718A4 (en) Microorganisms for the enhanced production of amino acids and related methods
MX2018016299A (es) Derivados de imidazo[1,2-a]piridina, métodos para preparar los mismos y uso de los mismos.
IL239330B (en) Triheptanoin for the treatment of glucose-1 transporter deficiency
ITUB20152376A1 (it) Lactobacillus paracasei per la produzione di acido linoleico coniugato, preparazioni nutrizionali e farmaceutiche che lo comprendono e loro uso
SG11201706722YA (en) Acid composition based on leonardite and amino acids
EP3322420A4 (en) BICYCLIC HETEROCYCLES AS INHIBITORS OF THE CHOLESTERALESTER TRANSFER PROTEIN
ZA201702385B (en) Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
EP3101396A3 (en) Sensor to detect clogged drain in freeze/thaw applications
DK3250711T3 (da) Fremgangsmåde og produkt til at forhindre falske positiver i fremgangsmåder anvendende ddntp'er
EP3288961B8 (en) Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
EP3204767A4 (en) Utility of protein in the prediction of in vivo effects
EP2709455A4 (en) PROCESSES FOR THE PREPARATION OF 5-AZASPIRO [2.4] HEPTANE-6-CARBOXYLIC ACID AND ITS DERIVATIVES
EP3205661A4 (en) Hsp70-derived peptide, and method of manufacturing pharmaceutical composition, immunity inducer, and antigen-presenting cell for cancer treatment or prevention using the same
EP3256455B8 (en) Method for the reduction of carboxylic acids or carbonic acid and their derivatives
EP3201288A4 (en) Synthetic acid compositions alternatives to conventional acids in the oil and gas industry
PT3009133T (pt) Resumo
EP2934501A4 (en) USES AND METHOD FOR THE TREATMENT OF LIVER DISEASES OR DRESSES
FR3002414B1 (fr) Composition rodenticide sous forme de cereales et/ou de graines agglomerees.